logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Trends & Strategies
  • Life Science & Technology Weekly 157 – Ascentage Pharma Officially Announces its Hong Kong IPO

Life Science & Technology Weekly 157 – Ascentage Pharma Officially Announces its Hong Kong IPO

NAI Life Science Weekly - www.nai500.com
Published on: Aug 23, 2018
Author: Editor
  • Share article:

Check www.nai500.com for more investment opportunities

 

Suggested Opportunity

Tenet Fintech Group Inc.

Tenet Fintech Group Inc. (CSE: PKK, OTC Pink: PKKFF)

Commercial Lending in China Ready to Tenet!

Click here to find more details

This is NAI’s new Life Science and Technology Weekly. We will be covering the latest news in life science, pharmaceutical, biotech and technology sectors every week. To continue to receive NAI’s Life Science and Technology Weekly, please click Here to subscribe.

Life Science Technology

Related Posts

OpenAI+迪士尼,10亿美元如何重塑娱乐业的未来?

Synopsys Aligns Interests with OpenAI, Paying by Results to Reduce Customer Concerns

微软Azure增速超越AWS和谷歌云,分析师揭秘原因

Google Releases Gemini 4 Argon, and AI Chip Capacity Has Already Been Bought Out

狗狗币本周大涨13%,但内在风险不容忽视

Swiss Central Bank Official Says Large Stablecoins May Weaken Monetary Policy Transmission

Lilly and Viking Just Showed the Obesity Market's Next Phase — and It's Not About Pounds

Lilly and Viking Just Showed the Obesity Market’s Next Phase — and It’s Not About Pounds

比特币投资的局限性与更具潜力的股票选择

Bitcoin’s Reversal Momentum Is Becoming Evident, and It May Return to $100,000 by Year-End

Boeing Re-Rating in the Spotlight After $2.38B F-15EX, Navy Fighter Wins

Boeing Re-Rating in the Spotlight After $2.38B F-15EX, Navy Fighter Wins

Related News

Synopsys Aligns Interests with OpenAI, Paying by Results to Reduce Customer Concerns

18 hours ago.

Google Releases Gemini 4 Argon, and AI Chip Capacity Has Already Been Bought Out

19 hours ago.

Swiss Central Bank Official Says Large Stablecoins May Weaken Monetary Policy Transmission

21 hours ago.

Lilly and Viking Just Showed the Obesity Market’s Next Phase — and It’s Not About Pounds

23 hours ago.

Top Stories

Micron's Revenue Quadruples as AI Memory Boom Fuels Push to Shed Its "Cyclical Stock" Label
Technology

Micron’s Revenue Quadruples as AI Memory Boom Fuels Push to Shed Its “Cyclical Stock” Label

TD Bank Just Announced a C$10 Billion Buyback — But That's Not the Reason to Own It
Financial Service

TD Bank Just Announced a C$10 Billion Buyback — But That’s Not the Reason to Own It

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada